Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Lucerne cast versus forearm cast with finger splint for proximal phalanx fractures.

Official title: Conservative Therapy of Proximal Phalanx Fractures - a Prospective Randomized Study Comparing the Lucerne Cast With Finger Splinting

Run by Medical University of Vienna · NCT06022419 · Data updated 2026-11-12

This trial tests whether the Lucerne cast gives better finger function than a forearm cast with a finger splint in adults with a proximal phalanx fracture.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment86 (estimated)
SponsorMedical University of Vienna
Academic / other
Locations1 site (Vienna)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedAugust 2027
Study endsFebruary 2028
Registry record updatedJune 15, 2025
Trial IDNCT06022419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with an acute proximal phalanx fracture of fingers II–V who can provide informed consent and present within seven days are ideal candidates.

Probably not a fit

Patients with intraarticular or condylar fractures, collateral ligament avulsions, compound or multiple hand injuries, polytrauma, pregnancy, or late presentation are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective randomized controlled trial comparing two conservative treatments for proximal phalanx fractures of fingers II–V. Adults aged 18–70 who meet inclusion criteria are randomized to receive either a Lucerne cast or a forearm cast with a finger splint, each applied for four weeks. Randomization follows CONSORT guidelines using the 'Randomizer' software, and clinical outcomes are assessed 12 weeks after injury. Key exclusions include intraarticular or condylar fractures, ligament avulsions, compound or multiple hand injuries, polytrauma, pregnancy, and delayed presentation beyond seven days.

Why it matters

Potential benefit: If successful, the Lucerne cast could improve finger function and recovery compared with standard forearm casting with a finger splint.

How similar studies have gone: Conservative casting for phalanx fractures is well established, but randomized comparisons specifically testing the Lucerne cast against forearm cast plus finger splint are limited, making this a relatively novel controlled comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Proximal phalanx fracture in the fingers (II - V)
* Patient age between 18 and 70 years

Exclusion Criteria:

* Condylar fracture
* Avulsions of the collateral ligament
* Pathologic fracture
* Intraarticular fracture
* Patients unable to consent
* Polytraumatized patients
* Patients initially presenting more than 7 days after injury
* Pregnancy
* Compound fractures
* Multiple hand injuries

Where it's running

  • Medical University of Vienna - Department of Orthopedics and Trauma-Surgery
    Vienna, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Comparing screws and pins for fixing broken fingers

    This study is testing whether using screws or pins works better for fixing broken fingers in adults and helps them recover faster with better hand function and satisfaction.

    Recruiting McMaster University · Hamilton, Ontario · NCT06372067

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.